Additionally, in stratified analyses, the risk of HCC was comparable between the HBeAg-loss group and the HBeAg-maintained group, irrespective of baseline age, serum levels of ALT and HBV DNA, and fibrotic burden. This evidence concerns the gene GPT and hepatocellular carcinoma.